Clinical Trials
24 trialsNCT02428101 2023-11-28
Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer
Ain Shams University
Unknown
NCT04654195 2020-12-04
Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient
Damanhour University
Unknown
NCT04581967 2020-10-09
Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients
Damanhour University
Unknown
NCT01185886 2017-07-28
Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
Unknown
NCT00967239 2015-05-08
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
NSABP Foundation Inc
Unknown
NCT00463034 2013-12-18
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT00467129 2013-12-18
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Unknown
NCT00691509 2013-08-26
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT00757211 2013-08-26
Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom
National Cancer Institute (NCI)
Unknown
NCT00757263 2013-08-26
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Unknown
NCT00757614 2013-08-26
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Unknown
NCT00757965 2013-08-26
Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom
National Cancer Institute (NCI)
Unknown
NCT00758056 2013-08-26
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Unknown
NCT00758173 2013-08-26
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
Unknown
NCT00896818 2013-08-26
Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
National Cancer Institute (NCI)
Unknown
NCT00514345 2013-08-12
CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
National Cancer Institute (NCI)
Unknown
NCT00536718 2013-08-12
Genetics of Women With Lobular Carcinoma in Situ of the Breast
National Cancer Institute (NCI)
Unknown
NCT00672321 2013-08-12
Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma
National Cancer Institute (NCI)
Unknown
NCT00693836 2013-08-12
Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region
National Cancer Institute (NCI)
Unknown
NCT00897871 2013-08-12
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
National Cancer Institute (NCI)
Unknown
NCT00935233 2013-08-12
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy Volunteers
National Cancer Institute (NCI)
Unknown
NCT01653613 2013-07-10
Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Unknown
NCT00897455 2011-03-23
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
National Cancer Institute (NCI)
Unknown
NCT01074398 2010-02-24
Biomarkers in Predicting Response in Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Treated on GOG-0172 or GOG-0182
National Cancer Institute (NCI)
Unknown